Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5245]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
TATTON: Updated results for patients with EGFR-mutant NSCLC
Prof Leica Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Updated results for patients with EGFR-mutant NSCLC ( Prof Leica Sequist - Massachusetts General Hospital, Boston, USA )
11 Apr 2019
Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients...
Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA
Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours ( Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA )
11 Apr 2019
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity...
Prof Shoba Navai - Baylor College of Medicine, Houston, USA
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )
11 Apr 2019
Umbralisib shows early promise for patients with marginal zone lymphoma
Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA
Umbralisib shows early promise for patients with marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )
11 Apr 2019
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell...
Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )
11 Apr 2019
Gilteritinib improved survival for patients with acute myeloid leukaemia
Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
Gilteritinib improved survival for patients with acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )
11 Apr 2019
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration...
Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas...
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-resistant prostate cancer (1/2) ( Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steuber )
10 Apr 2019
GU Debates 2019: Practice-changing developments in urothelial cancer (2/2)
GU Debates 2019: Practice-changing developments in urothelial cancer (2/2) ( )
9 Apr 2019
New developments in soft tissue and bone sarcoma research
Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands
New developments in soft tissue and bone sarcoma research ( Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands )
21 Mar 2019
Latest updates in melanoma research
Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam...
Latest updates in melanoma research ( Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Mar 2019
Gynaecological cancer: Where are we now?
Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands
Gynaecological cancer: Where are we now? ( Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands )
21 Mar 2019
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate...
Prof Karim Fizazi, Dr Eleni Efstathiou
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou )
15 Mar 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation